Notícia

The Peninsula Qatar (Catar)

Sinovac shot controlled Covid in Brazil town after 75% covered

Publicado em 31 maio 2021

The vaccine developed by Sinovac Biotech Ltd. was effective in controlling Covid-19 in a mass-inoculation study in a small Brazilian town after 75% of adults were covered with a second shot.

The study carried out by the Sao Paulo state government in the small town of Serrana -- population 45,000 -- may offer clues for other developing nations on how much of the public needs to be vaccinated in order to begin moving past the pandemic that continues to wreak havoc in Latin America and beyond.

The full results will be released during a press conference later on Monday with initial data broadcast on Sunday evening during TV Globo’s "Fantastico” program which interviewed researchers leading the project. While infection rates improved after first doses were administered, Covid-19 wasn’t properly controlled in the town until after a second shot was given, the researchers said.

The study was led by the Butantan Institute, which produces Sinovac’s so-called CoronaVac in Brazil. Almost two thirds of Serrana’s 45,000 inhabitants got the vaccine between February and April with another third ineligible to receive the shot if they were under 18 years old or pregnant. About 95% of the targeted adult population received the required two doses in the study.

While neighboring cities were being hit hard by the pandemic, Serrana saw deaths fall by 95% right after the mass-vaccination, symptomatic cases dropped by 80% and hospitalizations decreased by 86%, the report said. They didn’t say what time period was being used for the data.

Serrana mayor Leo Capitalize said in an interview that 40 days ago, 160-180 people were seeking a hospital bed on a daily basis and that test positivity rates were at 69%. Now, the number of people seeking attention in the hospital due to Covid is down to 30 to 35 people and positivity is down to 20%.

At the time the project was announced in February, Butantan researchers said the study aimed to show the effectiveness of CoronaVac to control cases, deaths and hospitalizations from Covid-19 in the real world, and if the shot is able to reduce transmission, not only symptomatic cases.

Sinovac’s vaccine is being used widely in the developing world including Chile, Turkey, Indonesia and the Philippines.

The findings also underline the importance of people returning for a second shot. In Brazil, some 66 million vaccines have been administered, covering 21.4% of the population with a single dose. About 10.5% of the country is now considered to be fully inoculated, according to the Bloomberg vaccine tracker.

Share this post

Russia's Navalny asks court to end prison security checks

31 May 2021 - 19:52

Lakers' depth in doubt for Game 5 in Phoenix

31 May 2021 - 19:42

'Time has come' for pandemic treaty as part of bold reforms - WHO's Tedros

31 May 2021 - 19:39

Please enable JavaScript to view the comments powered by Disqus.

Essa notícia também repercutiu nos veículos:
Folha.com Folha de S. Paulo BOL IstoÉ Dinheiro online Diário do Grande ABC online Estado de Minas online Correio Braziliense online Diário de Pernambuco online IstoÉ Dinheiro online UOL UOL UOL CBN Notícias (Campinas, SP) Folha.com Portal da TV Cultura Yahoo! Yahoo! Yahoo! Yahoo! Yahoo! Portal Exame UOL Diário do Poder G1 Portal R7 CBN Notícias G1 IstoÉ online UOL G1 EPTV TV Globo Valor Econômico online Folha.com O Estado de S. Paulo Estadão.com O Globo online O Globo online Agência Brasil Correio Braziliense online Revista Crescer online DOL - Diário Online A Crítica (MS) online Metropóles Pfarma Revista Revide Manancial News Notícias BH Público A Tabocas Notícias Você e Região Só Notícia Boa Diário GM Fleekus (EUA) Campos 24 horas Novo Dia Notícias online Clube de Imprensa Jornal Tempo News online Jornal de Piracicaba online RIC Mais Correio da Manhã Jornal (Portugal) SIC Notícias (Portugal) Informe Cidade TV Hortolândia Mix Vale Notícias ao Minuto Folha Noroeste online Portal Banda B DL News Portal Thathi Folha da Região (Araçatuba, SP) online Real Radio Tv Brasil Correio do Povo (Porto Alegre, RS) online Barulho Curitiba A Tribuna (Santos, SP) online Rádio Itatiaia Diário do Pará online Galileu online Archyde Dinheiro Rural online Meon Jornal do Oeste (Toledo, PR) online TN Online Tribuna de Petrópolis Tribuna do Sertão Hindustan Times (Índia) online Global Times (China) Metropóles Jornale A Crítica (MS) online Brasil 247 A Cidade On (São Carlos, SP) A Crítica (MS) online Veja São Paulo online ClickPB El Observador (Uruguai) TN Online Folha Vitória online RIC Mais Mix Vale DL News Crescer online SP Agora Portal Mídia Jornal Z Norte online Gazeta de Votorantim Bahia.ba Omny.fm Último Instante Último Instante Tribuna de Ituverava online Os Cabeças da Notícia Money Times Prime Time Zone (EUA) Radar Amazônico Diário do Sudoeste (Pato Branco, PR) online MSN O Brasileiro O Dia (Rio de Janeiro, RJ) online Olhar Digital Pais & Filhos online Forbes Brasil online SAPO Brasil Terra Portal do Holanda Repórter Diário São Carlos Agora SWI swissinfo.ch (Suíça) Sim Notícias Repórter Diário Terra Portal R3 Planeta online TNH1 Blog Vi o Mundo Super Rádio Tupi FM 96,5 Diário da Saúde Jornal da 3ª idade online Cidade Verde Campinas.com.br CGN Blog da Cidadania Instituto Butantan A Comarca Canaltech El País (Uruguai) online Diário da Manhã (RS, Passo Fundo) online Zero Hora online Índices Bovespa Democrata digital Eu, Rio! Zero Hora online Portal GMC Online Gazeta Brasil Consecti - Conselho Nacional de Secretários Estaduais para Assuntos de CT&I Blog A Crítica Investe São Paulo Reuters Brasil Portal da Enfermagem NewsLab online Portal do Governo do Estado de São Paulo Quimiweb Metropóles Revide Época Negócios online O Informante Pensar Piauí Portal Comunica AM! Portal Roma News O Anhanguera Leitura do Povo Itupeva Agora